Cargando…

The Hepatic Coma Syndromes and Lactulose

Detalles Bibliográficos
Autor principal:	Elias, Elwyn
Formato:	Texto
Lenguaje:	English
Publicado:	1979
Materias:	Book Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2595775/

Ejemplares similares

Combination of rifaximin and lactulose improves clinical efficacy and mortality in patients with hepatic encephalopathy
por: Wang, Zhida, et al.
Publicado: (2018)

Profile of Hepatic Encephalopathy in Children with Cirrhosis and Response to Lactulose
por: Sharma, Praveen, et al.
Publicado: (2011)

Multistrain probiotic and lactulose in the treatment of minimal hepatic encephalopathy
por: Shavakhi, Ahmad, et al.
Publicado: (2014)

Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence
por: Hudson, Mark, et al.
Publicado: (2019)

Polyethylene Glycol and Lactulose versus Lactulose Alone in the Treatment of Hepatic Encephalopathy in Patients with Cirrhosis: A Non-Inferiority Randomized Controlled Trial
por: Naderian, Mohammadreza, et al.
Publicado: (2017)

Efficacy and safety of lactulose for the treatment of irritable bowel syndrome
por: Chen, Hong-Bin, et al.
Publicado: (2019)

Lactulose, Disaccharides and Colonic Flora: Clinical Consequences
por: Clausen, Mette Rye, et al.
Publicado: (2012)

Lactulose for Minimal Hepatic Encephalopathy in Patients with Extrahepatic Portal Vein Obstruction
por: Sharma, Praveen, et al.
Publicado: (2012)

Lactulose enhances neuroplasticity to improve cognitive function in early hepatic encephalopathy
por: Yang, Nan, et al.
Publicado: (2015)

Real-World Experience of the One-Year Efficacy of Rifaximin Add-On to Lactulose Is Superior to Lactulose Alone in Patients with Cirrhosis Complicated with Recurrent Hepatic Encephalopathy in Taiwan
por: Chang, Ching, et al.
Publicado: (2021)

Comparison of Rifaximin and Lactulose for the Treatment of Hepatic Encephalopathy: A Prospective Randomized Study
por: Paik, Yong-Han, et al.
Publicado: (2005)

Recurrence of Hepatic Encephalopathy after TIPS: Effective Prophylaxis with Combination of Lactulose and Rifaximin
por: Seifert, Leon Louis, et al.
Publicado: (2021)

Lactulose in cirrhosis: Current understanding of efficacy, mechanism, and practical considerations
por: Bloom, Patricia P., et al.
Publicado: (2023)

Design and application of a lactulose biosensor
por: Wu, Jieyuan, et al.
Publicado: (2017)

Combination therapy with rifaximin and lactulose in hepatic encephalopathy: A systematic review and meta-analysis
por: Fu, Jian, et al.
Publicado: (2022)

Comparison of the effects of probiotics, rifaximin, and lactulose in the treatment of minimal hepatic encephalopathy and gut microbiota
por: Wang, Ming-Wei, et al.
Publicado: (2023)

Co-Administration of Lactulose Crystals with Amoxicillin Followed by Prolonged Lactulose Treatment Promotes Recovery of the Human Gut Microbiome In Vitro
por: Duysburgh, Cindy, et al.
Publicado: (2022)

Hepatic Coma Secondary to Fontan Conduit Thrombosis
por: Cavaco, João Luís, et al.
Publicado: (2023)

Baboon syndrome with lactulose: An apparently inert drug causing a systemic reaction
por: Agrawal, Diksha, et al.
Publicado: (2022)

Polyethylene glycol versus lactulose in the treatment of hepatic encephalopathy: a systematic review and meta-analysis
por: Hoilat, Gilles Jadd, et al.
Publicado: (2021)

Coma
por: Battey, Robert
Publicado: (1871)

Coma
por: Williams, J. F.
Publicado: (1889)

Alpha coma evolving into spindle coma in a case of acute fulminant hepatic failure: What does it signify?
por: Das, Abhijit, et al.
Publicado: (2010)

Association between Symptoms of Irritable Bowel Syndrome and Methane and Hydrogen on Lactulose Breath Test
por: Lee, Kang Nyeong, et al.
Publicado: (2013)

The effect of lactulose in prevention of ventilator associated pneumonia (VAP)
por: Zvonicek, V, et al.
Publicado: (2001)

Carnitine/cyclophosphamide/lactulose: Various toxicities: case report
Publicado: (2019)

Lactulose/rifaximin: Lack of drug effect: case report
Publicado: (2021)

The potential role of lactulose pharmacotherapy in the treatment and prevention of diabetes
por: Chu, Natural, et al.
Publicado: (2022)

Reduction in Gastrointestinal Cancers in Cirrhotic Patients Receiving Rifaximin vs Lactulose Only Therapy for Hepatic Encephalopathy
por: Patel, Ankoor H, et al.
Publicado: (2023)

Comparative Effectiveness and Safety of Polyethylene Glycol Electrolyte Solution Versus Lactulose for Treatment of Hepatic Encephalopathy: A Systematic Review and Meta-analysis
por: Li, Mengting, et al.
Publicado: (2022)

The "third coma" in diabetes: diabetic coma without ketoacidosis.
por: Grant, A. P.
Publicado: (1965)

Minimal Hepatic Encephalopathy in Indians: Psychometric Hepatic Encephalopathy Score and Inhibitory Control Test for Diagnosis and Rifaximin or Lactulose for Its Reversal
por: Pawar, Vinay B., et al.
Publicado: (2019)

Ogilvie's syndrome in a case of myxedema coma
por: Yanamandra, Uday, et al.
Publicado: (2012)

"Coma diabético" /
por: Martínez Ruíz, Silvia
Publicado: (1988)

Coma Hiperosmolar /
por: Arenas Benhumea, Gustavo
Publicado: (1987)

Coma Blisters
por: Rocha, Joana, et al.
Publicado: (2009)

Diabetic Coma
Publicado: (1891)

Diabetic Coma
Publicado: (1891)

Coma and Narcotism
Publicado: (1861)

Experimental Coma
Publicado: (1911)

Cannot write session to /tmp/vufind_sessions/sess_485o9s9gouu8l9f41fmqi4kiaf